Agilent Technologies, Inc.: Form 10-Q for the period ended Jul 31, 2015
Filed with the SEC on Sep 2, 2015 and accepted by EDGAR at Sep 2, 2015, 16:05 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-07-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2015-05-01 to 2015-07-31 | $1.01bn | us-gaap:SalesRevenueNet |
| Revenue | 9 months2014-11-01 to 2015-07-31 | $3.00bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2015-05-01 to 2015-07-31 | $501.0m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2014-11-01 to 2015-07-31 | $1.50bn | us-gaap:CostOfRevenue |
| Research and development | 3 months2015-05-01 to 2015-07-31 | $79.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2014-11-01 to 2015-07-31 | $248.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2015-05-01 to 2015-07-31 | $290.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2014-11-01 to 2015-07-31 | $892.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2015-05-01 to 2015-07-31 | $144.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2014-11-01 to 2015-07-31 | $366.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2015-05-01 to 2015-07-31 | $17.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2014-11-01 to 2015-07-31 | $50.0m | us-gaap:InterestExpense |
| Income tax | 3 months2015-05-01 to 2015-07-31 | $23.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2014-11-01 to 2015-07-31 | $42.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2015-05-01 to 2015-07-31 | $103.0m | us-gaap:ProfitLoss |
| Net income | 9 months2014-11-01 to 2015-07-31 | $258.0m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2015-05-01 to 2015-07-31 | $0.31 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2014-11-01 to 2015-07-31 | $0.77 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2015-05-01 to 2015-07-31 | $0.31 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2014-11-01 to 2015-07-31 | $0.77 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2015-05-01 to 2015-07-31 | 334,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2014-11-01 to 2015-07-31 | 336,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2014-11-01 to 2015-07-31 | $254.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2014-11-01 to 2015-07-31 | $71.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2014-11-01 to 2015-07-31 | $100.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2014-11-01 to 2015-07-31 | $267.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2015-07-31 | $2.08bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-07-31 | $3.48bn | us-gaap:AssetsCurrent |
| Total assets | At period end2015-07-31 | $7.25bn | us-gaap:Assets |
| Current liabilities | At period end2015-07-31 | $853.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2015-07-31 | $3.15bn | us-gaap:Liabilities |
| Long-term debt | At period end2015-07-31 | $1.66bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2015-07-31 | $4.10bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001090872-15-000039. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.